Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...

Q1 2025 Earnings Call Transcript May 1, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $4.9, expectations were ...

Q4 2024 Earnings Call Transcript April 30, 2025 PureTech Health plc beats earnings expectations. Reported EPS is $3.98, expectations were $-2.83. Operator: Greetings and welcome to the PureTech Health ...

Inhibikase (IKT) pivots to IkT-001Pro for PAH amid competition like Merck’s sotatercept. Backed by $97.5M, results will ...

A groundbreaking clinical trial replaces surgery with immunotherapy for cancer patients. The results could change cancer treatment, offering new hope for those with specific genetic mutations.

In the rapidly transforming world of artificial intelligence, where emerging technologies are reshaping industries at an ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research suggests that there might be a way to treat fatty liver disease.

Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins trading today.

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.